Prevalence and clinical profile of insulin resistance in young women of poly cystic ovary syndrome: A study from Pakistan

Pakistan Journal of Medical Sciences

Volumn 29, Issue 2, 2012, Pages

  Tabassum, Rumina ^a   Imtiaz, Fouzia ^a   Sharafat, Shaheen ^a   Shukar ud din, Shazia ^a   Nusrat, Uzma ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

Acanthosis nigrican; Insulin resistance; Poly cystic ovary syndrome; Waist hip ratio

Indexed keywords

GLUCOSE; INSULIN;

ACANTHOSIS NIGRICANS; ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PAKISTAN; PATIENT SELECTION; PREVALENCE; QUESTIONNAIRE; WAIST HIP RATIO;

EID: 84875064802     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.292.3180     Document Type: Article

References (25)

1. Stovall DW, Bailey AP, Pastore LM. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome. J Women Health. 2011;20(1):37-43.
2. Balen AH. Polycystic ovary syndrome & secondary amenorrhea D. Keith Edmonds. Dew Hurst's Textbook of Obstetrics & gynecology. 7th ed. Blackwell publishing: Oxford University Press; 2007.
3. Sheehan MT. Poly cystic ovarian syndrome: diagnosis and management. Clin Med Res. 2004;2(1):13-27.
4. Teede H, Deeks A, Moran L. Polycystic ovary syndrome; a complex condition with phsychological, reproductive and metabolic manifestations that impact on the health across the life span. BMC Med. 2010;8:41.
5. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril. 2003;8:19(1)-25.
6. Legro RS. Polycystic ovary syndrome, phenotype and genotype. Endocrinol Metab Clin North Am. 1999;28(2):379-396.
7. Tucci S, Futterweit W, Conception ES, Greenberg DA, Villanueva R, Davies TF, et al. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the Insulin receptor gene locus. J Cli Endocrinol Metab. 2001;86(1):446-449.
8. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83:1454-1460.
9. Dunaif A. Insulin resistance and polycystic ovarian syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774-800.
10. Vrbikova J, Dovrakova K. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovarian syndrome. Clin Chem Lab Med. 2007;45(5):639-644.
11. Kalra A, Nair S, Rai L. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome. Ind J Med Sci. 2006;60(11):447-453.
12. Sharma A, Yousef M, Burrill R, Atiomo W. Recent developments in polycystic ovary syndrome Studies J. Progress in Obstetrics and Gynaecology. Elsevier Churchill Livingstone. 2005;16(14):227-239.
13. Ovalle F, Aziz R. Insulin resistance, polycystic ovarian syndrome, and type 2 diabetes mellitus. Fertil Steril. 2002;77(6):1095-1105.
14. Kidson W. Polycystic Ovarian Syndrome: a new direction in treatment. Med J. 1998;169(10):537-540.
15. Al-Bayatti AA. Insulin resistance and upper body obesity in polycystic ovarian syndrome. Middle East Fertility Society J. 2006;11(3):202-209.
16. Mangangcha IR, Rathore VS, Singh IK, Bidyarani O. Metabolic characteristics of polycystic ovarian syndrome and its associated genetic polymorphisms in Indian women population. J Nat Sci Biol Med. 2011;2:138.
17. Riaz M, Basit A, Fawwad A, Ahmadani MY, Zafar A, Miyan Z, et al. Frequency of insulin resistance in patients with polycystic ovary syndrome: A study from Karachi, Pakistan. Pak J Med Sci. 2010;26(4):791-794.
18. Takeuchi T, Tsutsumi O, Taketani Y. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non obese patient with polycystic ovarian syndrome. Gynecol Endocrinol. 2008;24(7):385-391.
19. Haq F, Aftab O, Rizvi J. Clinical, biochemical and ultrasonographic features of infertile women Poly cystic ovarian syndrome. J Coll Physicians Surg Pak. 2007;17(2):76-80.
20. Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Tapanainen JS. Insulin sensitivity, insulin secreation, metabolic and hormonal parameters in healthy women and women with PCOS. Hum Reprod. 2000;15(4):1266-1274.
21. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618-637.
22. Lee H, Jee-Young O, Yeon-Ah S, Cho WY. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome. Endocrine. 2009;36(2):326-332.
23. Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome; a multicenter, double blind, placebocontrolled trial. J Clin Endocrinol Metab. 2001;86(4):1626-1632.
24. Wongwananuruk T, Rattanachaiyanont M, Indhavivadhana S, Leerasiri P, Techatraisak K, Tanmahasamut P, et al. Prevalence and clinical predictor of insulin resistance in reproductive aged Thai women with polycystic ovarian syndrome. Int J Endocrinol. 2012;2012:6.
25. Pantasri T, Vutyavanich T, Sreshthaputra O, Srisupundit K, Piromlertamorn W. Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome. J Med Assoc Thai. 2010;93(4):406-412.